Fresenius SE & CO. KGAA Detailed Consensus
Last Update: 2022-09-27

Please note: Consensus estimates are before special items.

KPI[EUR m]Q2 2021FY 2021Q2 2022FY 2022 E
SalesNumber of Estimates13
SalesConsensus (Mean)9,246.037,520.010,018.040,327.8
EBITNumber of Estimates13
EBITConsensus (Mean)1,033.04,252.01,003.04,296.5
Net interestNumber of Estimates9
Net interestHighest-480.0
Net interestConsensus (Mean)-121.0-504.0-116.0-507.3
Net interestMedian-509.0
Net interestLowest-542.0
TaxesNumber of Estimates8
TaxesConsensus (Mean)-196.0-848.0-204.0-855.6
Non-controlling interestNumber of Estimates9
Non-controlling interestHighest-886.3
Non-controlling interestConsensus (Mean)-241.0-1,033.0-233.0-1,005.3
Non-controlling interestMedian-1,000.0
Non-controlling interestLowest-1,080.3
Group net incomeNumber of Estimates13
Group net incomeHighest2,039.3
Group net incomeConsensus (Mean)475.01,867.0450.01,879.3
Group net incomeMedian1,920.6
Group net incomeLowest1,527.0
EPS (in EUR)Number of Estimates14
EPS (in EUR)Highest3.65
EPS (in EUR)Consensus (Mean)0.853.350.803.35
EPS (in EUR)Median3.42
EPS (in EUR)Lowest2.74
Average number of ordinary shares (in million)Number of Estimates13
Average number of ordinary shares (in million)Highest559.29
Average number of ordinary shares (in million)Consensus (Mean)557.77558.06560.08558.24
Average number of ordinary shares (in million)Median558.50
Average number of ordinary shares (in million)Lowest557.25
Fresenius Medical Care, SalesNumber of Estimates10
Fresenius Medical Care, SalesHighest19,753.1
Fresenius Medical Care, SalesConsensus (Mean)4,320.017,619.04,757.019,062.2
Fresenius Medical Care, SalesMedian19,135.5
Fresenius Medical Care, SalesLowest18,133.0
Fresenius Medical Care, EBITNumber of Estimates10
Fresenius Medical Care, EBITHighest2,160.2
Fresenius Medical Care, EBITConsensus (Mean)433.01,915.0445.01,908.2
Fresenius Medical Care, EBITMedian1,963.0
Fresenius Medical Care, EBITLowest1,494.0
Fresenius Kabi, SalesNumber of Estimates10
Fresenius Kabi, SalesHighest7,966.0
Fresenius Kabi, SalesConsensus (Mean)1,755.07,193.01,896.07,674.5
Fresenius Kabi, SalesMedian7,649.0
Fresenius Kabi, SalesLowest7,460.0
thereof biosimilars, salesNumber of Estimates2
thereof biosimilars, salesHighest133.0
thereof biosimilars, salesConsensus (Mean)--29.0108.9
thereof biosimilars, salesMedian108.9
thereof biosimilars, salesLowest84.9
Fresenius Kabi, EBITNumber of Estimates10
Fresenius Kabi, EBITHighest1,268.0
Fresenius Kabi, EBITConsensus (Mean)298.01,153.0271.01,140.7
Fresenius Kabi, EBITMedian1,124.6
Fresenius Kabi, EBITLowest1,051.0
Fresenius Helios, SalesNumber of Estimates10
Fresenius Helios, SalesHighest11,637.0
Fresenius Helios, SalesConsensus (Mean)2,738.010,891.02,925.011,487.4
Fresenius Helios, SalesMedian11,535.8
Fresenius Helios, SalesLowest11,169.0
Helios Germany, SalesNumber of Estimates6
Helios Germany, SalesHighest7,080.0
Helios Germany, SalesConsensus (Mean)1,675.06,733.01,758.06,999.6
Helios Germany, SalesMedian6,995.2
Helios Germany, SalesLowest6,935.0
Helios Spain, SalesNumber of Estimates6
Helios Spain, SalesHighest4,346.7
Helios Spain, SalesConsensus (Mean)1,020.04,021.01,101.04,265.3
Helios Spain, SalesMedian4,297.8
Helios Spain, SalesLowest4,117.0
Helios Fertility, SalesNumber of Estimates5
Helios Fertility, SalesHighest227.4
Helios Fertility, SalesConsensus (Mean)43.0137.065.0213.5
Helios Fertility, SalesMedian215.1
Helios Fertility, SalesLowest184.9
Fresenius Helios, EBITNumber of Estimates10
Fresenius Helios, EBITHighest1,228.7
Fresenius Helios, EBITConsensus (Mean)298.01,127.0303.01,205.7
Fresenius Helios, EBITMedian1,212.0
Fresenius Helios, EBITLowest1,180.0
Helios Germany, EBITNumber of Estimates6
Helios Germany, EBITHighest651.0
Helios Germany, EBITConsensus (Mean)152.0613.0154.0635.4
Helios Germany, EBITMedian634.3
Helios Germany, EBITLowest624.1
Helios Spain, EBITNumber of Estimates6
Helios Spain, EBITHighest593.9
Helios Spain, EBITConsensus (Mean)147.0514.0148.0553.3
Helios Spain, EBITMedian549.0
Helios Spain, EBITLowest527.0
Helios Fertility, EBITNumber of Estimates5
Helios Fertility, EBITHighest28.4
Helios Fertility, EBITConsensus (Mean)--7.020.0
Helios Fertility, EBITMedian18.5
Helios Fertility, EBITLowest15.1
Fresenius Vamed, SalesNumber of Estimates10
Fresenius Vamed, SalesHighest2,593.0
Fresenius Vamed, SalesConsensus (Mean)556.02,297.0562.02,496.7
Fresenius Vamed, SalesMedian2,505.9
Fresenius Vamed, SalesLowest2,389.0
Fresenius Vamed, EBITNumber of Estimates10
Fresenius Vamed, EBITHighest164.2
Fresenius Vamed, EBITConsensus (Mean)16.0101.011.0133.6
Fresenius Vamed, EBITMedian136.5
Fresenius Vamed, EBITLowest100.0
Corporate/Other, SalesNumber of Estimates10
Corporate/Other, SalesHighest-440.0
Corporate/Other, SalesConsensus (Mean)-123.0-480.0-122.0-485.4
Corporate/Other, SalesMedian-485.5
Corporate/Other, SalesLowest-510.0
Corporate/Other, EBITNumber of Estimates10
Corporate/Other, EBITHighest64.0
Corporate/Other, EBITConsensus (Mean)-12.0-44.0-27.0-74.3
Corporate/Other, EBITMedian-81.0
Corporate/Other, EBITLowest-141.0
USD/EUR (average)Number of Estimates2
USD/EUR (average)Highest1.0838
USD/EUR (average)Consensus (Mean)1.21001.18271.06001.0667
USD/EUR (average)Median1.0667
USD/EUR (average)Lowest1.0495

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.